Increased expression of the receptor (β1-integrin) and enhanced levels of its ligand (NC1-ColIVα5/pentastatin) suggest a higher susceptibility of endothelial cells to pentastatin in IPAH. This evidence concerns the gene COL18A1 and idiopathic pulmonary arterial hypertension.